Group 1 - The A-share market was active last week, with the Sci-Tech Innovation Board showing strong growth, particularly the Sci-Tech 50 Index which increased by 13.3% [1] - The communication, electronics, and computer sectors led the gains, driven by positive developments in domestic AI large models, including the release of DeepSeek-V3.1, which boosted sentiment in related industries such as domestic chips [1] - With the accumulation of positive factors in the industry and improved global liquidity expectations, the market's risk appetite is likely to be sustained, with the technology growth sectors (AI, semiconductors, military industry, etc.) experiencing upward momentum due to both domestic and external demand [1] Group 2 - The Guotai Sci-Tech Innovation Index ETF (589630) tracks the Sci-Tech Innovation Index (000680), with a daily fluctuation limit of up to 20%. This index covers over 560 listed companies on the Shanghai Stock Exchange's Sci-Tech Innovation Board, focusing on high-tech growth areas such as electronics, pharmaceuticals, and computers [1] - The Sci-Tech Innovation Index provides a comprehensive reflection of the overall performance of the Sci-Tech Innovation Board, particularly emphasizing the development of "hard technology" sectors [1] - Investors without stock accounts can consider the Guotai Shanghai Stock Exchange Sci-Tech Innovation Board Comprehensive ETF Initiated Link A (023733) and Link C (023734) [1]

Group 1 - The pan-technology industry is exhibiting a significant "head effect," with large-cap companies in technology and high-end manufacturing sectors (G1/G2 group) showing more pronounced gains, reflecting a trend towards investment strengthening [1] - The style of the AI industry chain is shifting from small and mid-cap stocks to mid and large-cap stocks, driven by enhanced institutional consensus, which is forming a favorable logic for sectors like trusted computing servers, IDC, and computing power leasing [1] - The implementation of new regulations for mobile power and lithium battery 3C certification is accelerating the industry's transition towards "safety + compliance," leading to the elimination of low-priced, low-quality products, which will enhance market concentration benefiting upstream high-safety battery cells and materials, midstream testing equipment, and downstream brand manufacturers [1] Group 2 - The Guotai Science and Technology Innovation Index ETF (589630) tracks the Science and Technology Innovation Index (000680), with a daily fluctuation of up to 20%, reflecting the overall performance of the Science and Technology Innovation Board [1] - The index consists of non-ST and *ST stocks listed on the Science and Technology Innovation Board for over a year, calculated using a total market capitalization weighting method, covering a wide range of securities with a strong representation in technology innovation sectors such as pharmaceuticals, computer software, high-end equipment, and new energy [1] - Investors without stock accounts can consider the Guotai SSE Science and Technology Innovation Board Comprehensive ETF Initiated Link A (023733) and Guotai SSE Science and Technology Innovation Board Comprehensive ETF Initiated Link C (023734) [1]

Group 1 - The Sci-Tech Innovation Index has shown strong performance among major broad-based indices, with an increase of 5.66%, ranking in the top three [1] - The current market is characterized by high investment prosperity, with the high prosperity index significantly outperforming the Shanghai Composite Index [1] - The technical timing model indicates a risk level of 106.24 for the Sci-Tech Innovation Index, with both short-term and medium-term trends showing upward movement, and an overall score of 36.30 [1] Group 2 - The Sci-Tech Innovation Index ETF, Guotai (589630), tracks the Sci-Tech Innovation Index (000680), with a daily fluctuation limit of 20% [1] - The index is composed of non-ST and *ST stocks listed on the Sci-Tech Innovation Board for over a year, using a total market capitalization weighting method to reflect the overall performance of listed companies [1] - The index covers a wide range of market capitalizations, with a significant concentration in the information technology and healthcare sectors, highlighting the Sci-Tech Innovation Board's focus on technological innovation [1] Group 3 - Investors without stock accounts can consider Guotai's CSI Sci-Tech Innovation Board Comprehensive ETF Initiated Link A (023733) and Guotai's CSI Sci-Tech Innovation Board Comprehensive ETF Initiated Link C (023734) [1]

Group 1 - The main index, the Sci-Tech Innovation Index, has shown strong performance, ranking among the top three in terms of growth, indicating continued market preference for the technology growth sector [1] - The communication (7.66%) and electronics (7.02%) sectors are leading the performance among the Shenwan first-level industries, confirming the market's preference for high-growth tracks [1] - The current market exhibits a "growth dominance" characteristic, with small-cap growth (5.07%) and growth style index (5.04%) showing significant gains, aligning with the strong performance of the Sci-Tech Innovation Index [1] Group 2 - The Sci-Tech Innovation Index ETF from Guotai (589630) tracks the Sci-Tech Innovation Index (000680), with a daily fluctuation limit of up to 20% [1] - This index covers nearly 97% of the listed companies on the Sci-Tech Innovation Board, with constituent stocks primarily in electronics, pharmaceuticals, machinery, and computers, characterized by high R&D investment and high self-developed technology content [1] - The Sci-Tech Innovation Index focuses on reflecting the performance of hard technology and strategic emerging industries, showcasing the overall market dynamics of the Sci-Tech Innovation Board [1]

（文章来源：每日经济新闻） 东方证券指出，AI应用方面，GPT-5主要提升在可靠性，价格低于GPT-4o，用户体验有望改善，国产模 型与GPT-5差距或进一步缩小，利好国内模型出海，人工智能正普及至生活各领域，量变积累成质变， 看好AI应用短期休整后卷土重来。机器人领域，人形机器人ChatGPT时刻或未来1-3年实现，出货量有 望每年翻番，全球首个人形机器人运动会将开幕。国产算力是国家发展基石，政策扶持下有望持续发 展，先进制程产能支持是关键，下半年或有催化。液冷板块渗透率及价值量或提升，国内公司有望突 破。信息化方面，AI与无人技术结合或成未来战争主要方式，市场关注度提升。商业卫星领域，近期 发射事件较多，未来还有更多催化。科技是确定性主线，人工智能为首的新质生产力将引领经济向好。 科创综指ETF国泰（589630）跟踪的是科创综指（000680），单日涨跌幅可达20%。该指数涵盖科创板 所有上市股票，以反映该板块整体表现。其成分股主要聚焦于科技创新企业，覆盖信息技术、生物医 药、高端制造等多个新兴科技领域，能够全面体现中国科技创新企业的市场动态与发展趋势。 ...

Group 1 - The current market trend is shifting from traditional cyclical sectors to technology sectors, influenced by policies and events [1] - The upcoming Fourth Plenary Session in October is expected to discuss development strategies for the next five years, accelerating capital towards high-tech and emerging industries [1] - The military parade on September 3 is anticipated to enhance investment expectations in the military industry, particularly in defense modernization and procurement [1] Group 2 - The easing expectations from the US-China summit may help alleviate trade and geopolitical tensions, creating a more favorable external environment for export-oriented technology companies [1] - The technology sector, particularly in AI and robotics, continues to exhibit structural growth logic, suggesting that the market's structural trend may persist [1] - The Guotai CSI Science and Technology Innovation ETF (589630) tracks the CSI Science and Technology Innovation Index (000680), which covers 97% of the market capitalization of the Sci-Tech Innovation Board [1] Group 3 - The index includes over 500 listed companies, primarily in high-tech industries such as semiconductors, power equipment, machinery manufacturing, and pharmaceuticals, characterized by high R&D investment and patent reserves [1] - Investors without stock accounts can consider the Guotai CSI Science and Technology Innovation ETF Initiated Link A (023733) and Link C (023734) [1]

科创综指ETF国泰（589630）跟踪的是科创综指（000680），单日涨跌幅可达20%。该指数从科创板中 选取全部符合条件的非ST、*ST股票作为指数样本，以反映科创板市场整体表现。科创综指覆盖了科技 创新型企业的广泛领域，在行业配置上重点聚焦信息技术、生物医药等高科技板块，具有较强的市场表 征力。 渤海证券指出，近期医药生物板块大幅上涨，创新药和CXO行情延续，催化不断。政策方面，近期出 台《支持创新药高质量发展的若干措施》及《关于开展第十一批国家组织药品集中采购相关药品信息填 报工作的通知》，从研发、准入、支付等全链条支持创新药发展，对制药及器械板块意义重大。业绩方 面，已披露业绩的CXO头部企业均有较好表现，呈现恢复态势，板块业绩拐点有望到来。展望后续， 建议关注受益于集采规则优化的制药和医疗器械板块，以及海外需求改善、订单逐步回暖的CXO板 块。创新药支持政策和商保创新药目录等重磅措施切实从全链条支持创新药发展，建立商保创新药目录 将有利于进一步明确基本医保保障边界，为创新药发展提供更充足的经济支撑。 没有股票账户的投资者可关注国泰上证科创板综合ETF发起联接A（023733），国泰上证科创板综合 ...

Group 1 - The technology sector is recommended as a key focus area until August 2025, driven by the positive trends in the AI industry chain and the current surge in software applications, indicating potential for further growth in domestic computing power and AI applications [1] - The pharmaceutical and biotechnology sectors, particularly innovative drugs, have shown significant price increases, with a long-term positive trend and some companies still having room for valuation recovery compared to their 2020 peaks [1] - The defense and military industry is expected to receive continuous catalysts, with the current fundamentals and confidence in the military sector being better than in historical years, driven more by fundamental factors than calendar effects [1] Group 2 - The Guotai Science and Technology Innovation Index ETF (589630) tracks the Science and Technology Innovation Index (000680), which can experience daily fluctuations of up to 20%, covering nearly 97% of the market capitalization of the Science and Technology Innovation Board [1] - The index emphasizes technological innovation and growth, with a balanced industry distribution aimed at reflecting the overall performance of the Science and Technology Innovation Board market [1] - Investors without stock accounts can consider the Guotai Science and Technology Innovation Board Comprehensive ETF Initiated Link A (023733) and Link C (023734) [1]

国泰海通指出，新兴科技是市场主线，新技术趋势与消费动向带来新商业机会，看好港股互联网、传 媒、国防军工、创新药、电子半导体等领域。电子行业方面，自主可控趋势加速，国产替代前景可期； 计算机行业受益于"人工智能+"政策驱动，AI应用迎来顶层支持；军工行业受抗战80周年阅兵等事件催 化，延续高景气度；机械领域关注人形机器人技术演进，线性运动部件需求提升。此外，煤炭行业反内 卷深化，供需格局逐步改善；公用事业中部分区域旺季电价或上涨，煤电主业盈利修复。整体来看，科 技产业创新持续涌现，资本开支上升趋势明确，为相关行业提供增长动能。 （文章来源：每日经济新闻） 科创综指ETF国泰（589630）跟踪的是科创综指（000680），单日涨跌幅可达20%。该指数涵盖科创板 所有上市股票，以反映该板块证券的整体表现。科创综指成分股主要聚焦科技创新领域，覆盖信息技 术、生物医药、新能源等多个高新技术产业，具有研发投入强度高、成长性突出的特征。 ...

8月11日，科创综指ETF国泰（589630）涨超1.3%，科技板块补涨动力受关注。 中银国际指出，2025年8月科技板块仍是重点推荐行业，考虑AI产业链景气趋势，特别是当前软件 应用端迎来密集催化，国产算力性能提升，国产算力和AI应用或仍有补涨动力。近期医药生物特别是 创新药涨幅明显，7月1日-8月1日涨幅达21%，长期趋势向好，部分公司估值距2020年高点仍有一定距 离，CRO业绩回暖、仍具上涨空间。"9.3"阅兵在即，国防军工板块有望受到持续催化，同时关注部分 消费行业如轻工制造、美容护理，部分具备困境反转动力行业如电力设备、基础化工等。 科创综指ETF国泰（589630）跟踪的是科创综指（000680），单日涨跌幅可达20%。该指数覆盖科 创板约97%市值，成分股涵盖大、中、小盘科技企业，行业分布均衡，聚焦于新一代信息技术、生物医 药等战略新兴产业，以反映具备高研发投入与科技创新能力的上市公司证券的整体表现。 每日经济新闻 （责任编辑：董萍萍 ） 没有股票账户的投资者可关注国泰上证科创板综合ETF发起联接A（023733），国泰上证科创板综 合ETF发起联接C（023734）。 注：如提及个股仅供参考 ...